{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:24:45Z","timestamp":1778631885243,"version":"3.51.4"},"reference-count":152,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.seminoncol.2011.11.011","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T17:03:13Z","timestamp":1327942993000},"page":"97-108","source":"Crossref","is-referenced-by-count":48,"title":["p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies"],"prefix":"10.1053","volume":"39","author":[{"given":"Yogen","family":"Saunthararajah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Triozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Rini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Radivoyevitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkael","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Advani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Reu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Kalaycio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Lichtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Bolwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2011.11.011_bib1","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib2","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V97.11.3589","article-title":"FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia","volume":"97","author":"Stirewalt","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.1115","article-title":"Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents","volume":"31","author":"Andersen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/gcc.20193","article-title":"Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile","volume":"43","author":"Schoch","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib5","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.0602402103","article-title":"Loss of p53 impedes the antileukemic response to BCR-ABL inhibition","volume":"103","author":"Wendel","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib6","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1158\/1078-0432.CCR-04-0598","article-title":"CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes","volume":"10","author":"Suarez","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrd2656","article-title":"The genetics of the p53 pathway, apoptosis and cancer therapy","volume":"7","author":"Vazquez","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/427201a","article-title":"Tumour suppression: putting on the brakes","volume":"427","author":"Harris","year":"2004","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.immuni.2007.06.004","article-title":"Myeloid lineage commitment from the hematopoietic stem cell","volume":"26","author":"Iwasaki","year":"2007","journal-title":"Immunity"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib10","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1073\/pnas.94.24.13187","article-title":"Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT\/enhancer binding protein epsilon-deficient mice","volume":"94","author":"Yamanaka","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2004-08-3346","article-title":"The transcriptional program of terminal granulocytic differentiation","volume":"105","author":"Theilgaard-Monch","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1101\/gad.1903410","article-title":"Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis","volume":"24","author":"Klusmann","year":"2010","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2141.2007.06909.x","article-title":"Familial myelodysplasia and acute myeloid leukaemia\u2014a review","volume":"140","author":"Owen","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-10-2422","article-title":"Noncytotoxic differentiation treatment of renal cell cancer","volume":"71","author":"Negrotto","year":"2011","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood.V112.11.201.201","article-title":"Differentiation-chronology specific function of DNMT1 and selective anti-leukemia stem-cell therapy","volume":"112","author":"Negrotto","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/leu.2011.159","article-title":"p53 Independent epigenetic differentiation treatment in xenotransplant models of acute myeloid leukemia","volume":"25","author":"Ng","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1182\/blood.V98.4.897","article-title":"Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT\/enhancer-binding protein epsilon","volume":"98","author":"Nakajima","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2002-05-1374","article-title":"CCAAT\/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia","volume":"101","author":"Truong","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood-2003-01-0159","article-title":"C\/EBPepsilon interacts with retinoblastoma and E2F1 during granulopoiesis","volume":"103","author":"Gery","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib20","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1074\/jbc.M600575200","article-title":"N-terminal region of CCAAT\/enhancer-binding protein epsilon is critical for cell cycle arrest, apoptosis, and functional maturation during myeloid differentiation","volume":"281","author":"Nakajima","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib21","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1038\/onc.2008.285","article-title":"C\/EBPalpha and C\/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene","volume":"27","author":"Matsushita","year":"2008","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1182\/blood-2003-07-2391","article-title":"Identification of the molecular requirements for an RAR alpha-mediated cell cycle arrest during granulocytic differentiation","volume":"103","author":"Walkley","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0925-4773(99)00325-1","article-title":"The molecular basis of lung morphogenesis","volume":"92","author":"Warburton","year":"2000","journal-title":"Mech Dev"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(02)00762-6","article-title":"Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability","volume":"109","author":"McGill","year":"2002","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1755-148X.2009.00578.x","article-title":"Frequent mutations in the MITF pathway in melanoma","volume":"22","author":"Cronin","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib26","first-page":"954","article-title":"Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid","volume":"119","author":"Passeron","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.26320","article-title":"Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo","author":"Alcazar","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1101\/gad.1182504","article-title":"Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers","volume":"18","author":"Kho","year":"2004","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1101\/gad.1765109","article-title":"MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state","volume":"23","author":"Yang","year":"2009","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(01)00528-3","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma","volume":"132","author":"Sandberg","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1568008043339802","article-title":"The PAX8\/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma","volume":"4","author":"McIver","year":"2004","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1193-230","article-title":"Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma","volume":"5","author":"Galili","year":"1993","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<7::AID-GCC2>3.0.CO;2-0","article-title":"Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma","volume":"17","author":"Weber-Hall","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00244478","article-title":"Localization of X chromosome short arm markers relative to synovial sarcoma- and renal adenocarcinoma-associated translocation breakpoints","volume":"92","author":"Sinke","year":"1993","journal-title":"Hum Genet"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc1947","article-title":"Lineage dependency and lineage-survival oncogenes in human cancer","volume":"6","author":"Garraway","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib38","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","article-title":"Stem cell concepts renew cancer research","volume":"112","author":"Dick","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","article-title":"Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells","volume":"112","author":"Taussig","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2008.02.008","article-title":"Modeling of C\/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells","volume":"13","author":"Kirstetter","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib43","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/sj.leu.2404754","article-title":"Aberrant marker expression patterns on the CD34+","volume":"21","author":"van Rhenen","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib44","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1182\/blood.V89.9.3104","article-title":"Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo","volume":"89","author":"Blair","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0301-472X(00)00155-7","article-title":"Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117)","volume":"28","author":"Blair","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","article-title":"Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia","volume":"19","author":"Goardon","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib47","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/leu.2010.158","article-title":"AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3","volume":"24","author":"Wunderlich","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/sj.leu.2402882","article-title":"Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD\/SCID mice and in NOD\/SCID mice transgenic for human growth factors","volume":"17","author":"Feuring-Buske","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib49","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/ijc.23772","article-title":"Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD\/scid-related strains","volume":"123","author":"Agliano","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI41495","article-title":"Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2Rgammac-deficient mice","volume":"121","author":"Sarry","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib51","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood.V90.12.5002","article-title":"AC133, a novel marker for human hematopoietic stem and progenitor cells","volume":"90","author":"Yin","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib54","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.09.010","article-title":"A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs","volume":"143","author":"Kim","year":"2010","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib57","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0960-9822(01)00154-3","article-title":"c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny","volume":"11","author":"Arnold","year":"2001","journal-title":"Curr Biol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib59","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1182\/blood-2010-10-312512","article-title":"RUNX1 regulates corepressor interactions of PU.1","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2011.207","article-title":"CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors","author":"Negrotto","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-10-401","article-title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","volume":"10","author":"Rocquain","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib63","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/leu.2010.167","article-title":"Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies","volume":"24","author":"Makishima","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib65","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1182\/blood-2010-05-267096","article-title":"Polycomb proteins in hematologic malignancies","volume":"116","author":"Martin-Perez","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications\u2014miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib67","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1073\/pnas.0401994101","article-title":"Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression","volume":"101","author":"Rhodes","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Spec No 1","key":"10.1053\/j.seminoncol.2011.11.011_bib68","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1093\/hmg\/ddm021","article-title":"Cancer genetics of epigenetic genes","volume":"16","author":"Miremadi","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib69","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/jnci\/djq520","article-title":"Targeted epigenetic therapies: the next frontier?","volume":"102","author":"Tuma","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib70","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","article-title":"Aberrant DNA methylation is a dominant mechanism in MDS progression to AML","volume":"113","author":"Jiang","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib71","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nature03672","article-title":"Global histone modification patterns predict risk of prostate cancer recurrence","volume":"435","author":"Seligson","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib72","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2353\/ajpath.2009.080874","article-title":"Global levels of histone modifications predict prognosis in different cancers","volume":"174","author":"Seligson","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib73","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2407-10-387","article-title":"Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients","volume":"10","author":"Advani","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib74","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1200\/JCO.2007.11.2599","article-title":"Global histone modifications predict prognosis of resected non small-cell lung cancer","volume":"25","author":"Barlesi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib75","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2009.24.5639","article-title":"Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704","volume":"28","author":"Manuyakorn","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib76","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","article-title":"Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome","volume":"69","author":"Elsheikh","year":"2009","journal-title":"Cancer Res"},{"issue":"Spec No 1","key":"10.1053\/j.seminoncol.2011.11.011_bib77","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddm051","article-title":"Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis","volume":"16","author":"Clark","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib78","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.exphem.2011.01.008","article-title":"Quiescence regulators for hematopoietic stem cell","volume":"39","author":"Li","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib79","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","article-title":"Aberrant DNA methylation is a dominant mechanism in MDS progression to AML","volume":"113","author":"Jiang","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib80","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1073\/pnas.0800467105","article-title":"Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells","volume":"105","author":"Postovit","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib81","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1116447","article-title":"Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells","volume":"309","author":"Cowan","year":"2005","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-4598-10-7","article-title":"Epigenetic reprogramming of breast cancer cells with oocyte extracts","volume":"10","author":"Allegrucci","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib83","first-page":"8955","article-title":"Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts","volume":"63","author":"Gozzini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib84","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2401508","article-title":"Histone deacetylase inhibitors are the potent inducer\/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy","volume":"13","author":"Kosugi","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib85","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood-2009-01-198911","article-title":"Differentiation therapy of leukemia: 3 decades of development","volume":"113","author":"Nowak","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib86","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1471-4892(03)00081-X","article-title":"Differentiation therapy","volume":"3","author":"Spira","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib87","first-page":"1755","article-title":"Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells","volume":"3","author":"Gore","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib88","first-page":"2766","article-title":"Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells","volume":"59","author":"Wang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1103581","article-title":"Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins","volume":"76","author":"Moldenhauer","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0163-7258(94)00053-6","article-title":"The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes","volume":"65","author":"Haaf","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib91","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/MCB.25.11.4727-4741.2005","article-title":"5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal","volume":"25","author":"Ghoshal","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(80)90237-8","article-title":"Cellular differentiation, cytidine analogs and DNA methylation","volume":"20","author":"Jones","year":"1980","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib93","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood.V64.4.922.922","article-title":"5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias","volume":"64","author":"Pinto","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib94","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)68144-5","article-title":"Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine","volume":"257","author":"Creusot","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2141.2001.02523.x","article-title":"Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3","volume":"112","author":"Niitsu","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2004.08.022","article-title":"Probing p53 biological functions through the use of genetically engineered mouse models","volume":"576","author":"Attardi","year":"2005","journal-title":"Mutat Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib97","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib98","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/jnci\/djp342","article-title":"Epigenetic therapies move into new territory, but how exactly do they work?","volume":"101","author":"Tuma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib99","first-page":"5511","article-title":"Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells","volume":"46","author":"Covey","year":"1986","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib100","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1093\/nar\/gkm432","article-title":"Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation","volume":"35","author":"Schermelleh","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib101","first-page":"1636","article-title":"In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine","volume":"37","author":"Momparler","year":"1977","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib102","doi-asserted-by":"crossref","first-page":"e4563","DOI":"10.1371\/journal.pone.0004563","article-title":"Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications","volume":"4","author":"Halaban","year":"2009","journal-title":"PloS ONE"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib103","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2003-05-1738","article-title":"Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib104","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","article-title":"A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice","volume":"85","author":"Fero","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)81238-6","article-title":"Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)","volume":"85","author":"Kiyokawa","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib106","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","article-title":"Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors","volume":"85","author":"Nakayama","year":"1996","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1365-2141.2000.02253.x","article-title":"Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation","volume":"110","author":"Furukawa","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib108","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V114.22.2077.2077","article-title":"Non-p53 dependent, leukemia initiating-cell selective, therapy","volume":"114","author":"Ng","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib109","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1158\/1535-7163.MCT-10-0191","article-title":"Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus","volume":"9","author":"Hu","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.E07-06-0528","article-title":"Chromatin challenges during DNA replication: a systems representation","volume":"19","author":"Kohn","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib111","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/blood-2003-07-2431","article-title":"Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A","volume":"103","author":"Milhem","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib112","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"De Felice","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib113","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells","volume":"65","author":"Bug","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib114","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14653240410004899","article-title":"Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal","volume":"6","author":"Young","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/gene.10250","article-title":"Histone deacetylase activity is required for embryonic stem cell differentiation","volume":"38","author":"Lee","year":"2004","journal-title":"Genesis"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib116","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.exphem.2005.10.002","article-title":"Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents","volume":"34","author":"Araki","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib117","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajh.20178","article-title":"5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells","volume":"77","author":"Suzuki","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib118","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1182\/blood-2009-01-197780","article-title":"Undifferentiated hematopoietic cells are characterized by a genome-wide undermethylation dip around the transcription start site and a hierarchical epigenetic plasticity","volume":"114","author":"Chung","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1097-0142(196109\/10)14:5<1017::AID-CNCR2820140516>3.0.CO;2-P","article-title":"An in vitro and in vivo study of differentiation in teratocarcinomas","volume":"14","author":"Pierce","year":"1961","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0145-2126(84)90099-7","article-title":"Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia","volume":"8","author":"Michalewicz","year":"1984","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib121","first-page":"337","article-title":"Induction and differentiation of an epithelial tumour in the newt (Triturus cristatus)","volume":"10","author":"Seilern-Aspang","year":"1962","journal-title":"J Embryol Exp Morphol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib122","first-page":"949","article-title":"All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia","volume":"100","author":"Huang","year":"1987","journal-title":"Chin Med J (Engl)"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib123","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib124","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1182\/blood-2007-10-117762","article-title":"The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph\u2212 acute lymphoblastic leukemia cells","volume":"111","author":"Scuto","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib125","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib126","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib127","first-page":"339","article-title":"Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic tissues in AKR mice","volume":"15","author":"Sorm","year":"1968","journal-title":"Neoplasma"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0145-2126(81)90116-8","article-title":"Phase I study on 5-aza-2'-deoxycytidine in children with acute leukemia","volume":"5","author":"Rivard","year":"1981","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2006-05-021162","article-title":"Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib130","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1200\/JCO.2008.19.6550","article-title":"Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial","volume":"27","author":"Steensma","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/426125a","article-title":"Cancer robustness: tumour tactics","volume":"426","author":"Kitano","year":"2003","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib132","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2006.09.042","article-title":"Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment","volume":"127","author":"Anderson","year":"2006","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib133","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21792","article-title":"Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib134","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/cncr.22508","article-title":"Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cncr.22376","article-title":"Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib136","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2011-03-341909","article-title":"A pilot study of subcutaneous decitabine in \u03b2-thalassemia intermedia","volume":"118","author":"Olivieri","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib137","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/rcm.2423","article-title":"Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography\/tandem mass spectrometry quantification method","volume":"20","author":"Liu","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib138","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/newbio233109a0","article-title":"Cytidine deaminase and the development of resistance to arabinosyl cytosine","volume":"233","author":"Steuart","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib139","first-page":"1115","article-title":"Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells","volume":"12","author":"Ohta","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib140","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0145-2126(90)90067-J","article-title":"Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine","volume":"14","author":"Momparler","year":"1990","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib141","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.leu.2404595","article-title":"A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemia","volume":"21","author":"Yin","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib142","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/0008-5472.CAN-03-2456","article-title":"The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines","volume":"64","author":"Ge","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib143","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2141.1999.01338.x","article-title":"Leukaemic blasts differ from normal bone marrow mononuclear cells and CD34+ haemopoietic stem cells in their metabolism of cytosine arabinoside","volume":"105","author":"Braess","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib144","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2008-02-140038","article-title":"Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines","volume":"113","author":"Qin","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00686404","article-title":"Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response","volume":"30","author":"Kreis","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib146","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1158\/1078-0432.CCR-07-4885","article-title":"Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine","volume":"14","author":"Beumer","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib147","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib148","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.20500","article-title":"Identification of genes with abnormal expression changes in acute myeloid leukemia","volume":"47","author":"Stirewalt","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib149","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2164-8-264","article-title":"Genomic expression during human myelopoiesis","volume":"8","author":"Ferrari","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib150","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1073\/pnas.0900089106","article-title":"Dysregulated gene expression networks in human acute myelogenous leukemia stem cells","volume":"106","author":"Majeti","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib151","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2008.07431.x","article-title":"A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia","volume":"144","author":"Cheung","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2011.11.011_bib152","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775411003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T08:18:06Z","timestamp":1640593086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775411003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0093775411003009"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2011.11.011","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}